Drought and salinity are among the worst scourges of agriculture. One effective mechanism to reduce damage from these stresses is the accumulation of high intracellular levels of osmoprotectant compounds. These compounds include proline, ectoine, betaines, polyols, and trehalose, and have evolved in many different organisms. Since some crop plants have low levels of these osmoprotectants or none at all, engineering osmoprotectant biosynthesis pathways is a potential way to improve stress tolerance. First-generation engineering work -much of it with single genes -has successfully introduced osmoprotectant pathways into plants that lack them naturally, and this has often improved stress tolerance. However, the engineered osmoprotectant levels are generally low and the increases in tolerance commensurately small. To get beyond trace levels of osmoprotectants and marginal tolerance increments we need to diagnose what limits osmoprotectant levels in engineered plants, and to use additional genes to overcome these limitations.
INTRODUCTION
Drought and salinity are major limitations on crop productivity and quality in the US and globally. For example, about 25% of US land is subject to drought, and 20% of cultivated land worldwide is affected by salinity (Boyer, 1982; Tanji, 1990) . Increasing the resistance of crops to these osmotic stresses was one of the first objectives of plant metabolic engineering (LeRudulier et al., 1984) , and remains a major goal today (Sakamoto and Murata, 2001 ).
One way many plants and other organisms cope with osmotic stress is to synthesize and accumulate compounds termed osmoprotectants (or compatible solutes). These are small, electrically neutral molecules that are non-toxic at molar concentrations, and stabilize proteins and membranes against the denaturing effect of high concentrations of salts and other harmful solutes (Yancey, 1994) . The physicochemical basis of this protective effect involves the exclusion of osmoprotectant molecules from the hydration sphere of proteins (Timasheff, 1992) . This creates a situation where native protein structures are thermodynamically favored because they present the least possible surface area to the water. In contrast, salts enter the hydration sphere and interact directly with protein surfaces, favoring unfolding. In dry or saline environments osmoprotectants can therefore serve both to raise cellular osmotic pressure and to protect cell constituents. Their protective effects also extend to temperature extremes and other stresses (Yancey, 1994) .
Chemically, osmoprotectants are of three types ( Fig. 1 ): betaines (fully N-methylated amino acid derivatives) and related compounds such as dimethylsulfoniopropionate (DMSP) and choline-Osulfate; certain amino acids like proline and ectoine; and polyols and nonreducing sugars such as trehalose. Not all of these occur in crop plants. However, an important feature of osmoprot-ectants is that their beneficial effects are generally not species-specific, so that alien osmoprotectants can be engineered into plants and protect their new host.
In plants that naturally accumulate osmoprotectants, the levels are typically 5-50 µmol g -1 fresh
weight (~6-60 mM on a plant water basis) and are highest during exposure to osmotic stress since accumulation is usually to some extent stress-induced (Rhodes and Hanson, 1993; Bohnert et al., 1995) . In plant cells, osmoprotectants are typically confined mainly to the cytosol, chloroplasts, and other cytoplasmic compartments that together occupy 20% or less of the volume of mature cells (the other 80% is the large central vacuole). Natural osmoprotectant concentrations in cytoplasmic compartments can therefore reach or exceed 200 mM. Such concentrations are osmotically significant, and so have pivotal roles in maintaining cell turgor and the driving gradient for water uptake under stress (Rhodes and Samaras, 1994) .
Of the osmoprotectants in Figure 1 , proline, glycine betaine (GlyBet), and mannitol occur commonly in plants, while DMSP, choline-O-sulfate, D-ononitol, and trehalose occur rarely, and ectoine is found only in bacteria. Biosynthetic enzymes for most of these compounds, plus some others, have been used to engineer plants (Table 1) . Table 1 is designed to illustrate several general points. First, the genes used come more often than not from microorganisms, even when a pathway also occurs in plants (this is usually because the plant genes were not cloned when the project began). Second, while there is some work on major crops, most is with the model plants Arabidopsis and tobacco. Third, projects involving one gene outnumber those involving two or three, and constitutive promoters (CaMV 35S, NOS) are almost always used, although osmoprotectant production is usually stress-induced in nature. Fourth, the engineered levels of osmoprotectants generally fall far short of natural levels, but these low levels have nevertheless often 4 measurably increased stress tolerance under laboratory conditions. A fifth point, not shown in Table 1 , is that intermediate pool sizes or fluxes are seldom measured, which precludes diagnosis of why the osmoprotectant levels achieved are not higher (Nuccio et al., 1999) . In the rest of this article, we will expand on these points by focusing on the engineering of three compoundsectoine, GlyBet, and trehalose. Work on these three adequately represents the whole field.
ECTOINE
Ectoine occurs in Halomonas elongata and other halophilic bacteria, which synthesize it from aspartate semialdehyde in three steps ( Fig. 2 ) (Ono et al., 1999) . The three H. elongata genes (ectA, ectB, and ectC) encoding the enzymes of ectoine synthesis were each placed under the control of the constitutive CaMV 35S promoter in a single construct, which was introduced into cultured tobacco cells (Nakayama et al., 2000) . Transformed cell lines synthesized low levels of ectoine (≤79 nmol g -1 fresh weight) and showed a small increase in resistance to osmotic stress imposed with mannitol (Nakayama et al., 2000) .
This work is exceptional in having expressed three genes at once using a single construct, which is difficult in plants, particularly when the same promoter is used for all the genes because this predisposes to gene silencing (De Wilde et al., 2000) . (Commoner routes are to introduce genes singly and then combine them by sexual crossing, or to add them sequentially using a different selectable marker each time.) However, the work is otherwise typical in that just a trace of osmoprotectant was produced, and because no investigation was made to find why. Possibilities include: (a) poor translation of one or more of the bacterial sequences due to divergent codon preferences in bacteria and plants: (b) low availability of the aspartate semialdehyde and acetylCoA substrates in the cytosol where the ectoine enzymes were presumably expressed, since these 5 intermediates may be made and used chiefly in chloroplasts (Nawrath et al., 1994; Galili, 1995) ;
and (c) degradation of ectoine. These three problems -codon bias, compartmentation, and catabolism -are recurrent ones in plant metabolic engineering.
GLYCINE BETAINE
GlyBet occurs in some but not all higher plants, as well as in bacteria and other organisms. In all cases, it is synthesized by a two-step oxidation of choline via betaine aldehyde, but different enzymes are involved (Fig. 3) . In Escherichia coli, a membrane-bound, electron transfer-linked choline dehydrogenase (CDH) oxidizes choline to betaine aldehyde. The aldehyde is then oxidized to GlyBet by a soluble, NAD-linked betaine aldehyde dehydrogenase (BADH) (Andresen et al., 1988) . In contrast, Arthrobacter spp. bacteria have a soluble choline oxidase (COX) that carries out both oxidation steps and generates H 2 O 2 (Ikuta et al., 1977) . In plants, the first oxidation is mediated by a ferredoxin-dependent choline monooxygenase (CMO) (Rathinasabapathi et al., 1997) and the second by BADH (Rathinasabapathi et al., 1994) . Both plant enzymes are chloroplastic. All these enzymes have been used to engineer tobacco and other plants that lack GlyBet, generally by placing the transgenes under the control of the CaMV 35S promoter, and in most cases some increase in stress tolerance has been reported. GlyBet is not appreciably degraded in plants (Rhodes and Hanson, 1993; Nuccio et al., 1998) so that GlyBet catabolism has not been an important engineering consideration.
Engineering with CDH
E. coli CDH has been introduced into tobacco alone and together with E. coli BADH (Lilius et al., 1996; Holmstrom et al., 2000) . Advanced features of the latter work were use of a leafspecific promoter to drive CDH expression, and removal of a possible polyadenylation signal in 6 the CDH coding region to forestall premature termination of the transcript (Holmstrom et al., 2000) . CDH-only and CDH/BADH transformants nevertheless accumulated only small amounts of GlyBet (≤66 nmol g -1 fresh weight). The betaine aldehyde formed in the CDH-only transgenics was presumably oxidized to GlyBet by the low endogenous BADH activity in tobacco (Rathinasbapathi et al., 1994) . However, this was not investigated directly, and nor were other factors that might have limited flux to GlyBet. Although CDH activities or protein levels were analyzed, the subcellular localization of CDH and its in planta electron acceptor(s) were not. As CDH resides in an electron transport chain in E. coli, its activity in plants could be limited by lack of suitable electron acceptor in the membrane(s) it inserts in, if insertion indeed occurs.
Moreover, membrane insertion could restrict access to endogenous choline pools. Thus, these studies demonstrated that CDH can be used to install GlyBet synthesis but they did not show how CDH works in plants, or what constrains GlyBet accumulation.
Engineering with COX
Arthrobacter COX has been introduced into several plant species, either as the unmodified protein or with a chloroplast targeting sequence added (see review by Sakamoto and Murata, 2001 ).
Levels of GlyBet achieved with COX are substantially higher than with CDH, typically 1-2 mol g -1 fresh weight, but still well below levels in natural GlyBet accumulators like spinach and sugar beet. Although Arabidopsis, canola, and rice express COX at high levels, tobacco -for unknown reasons -does not (Sakamoto et al., 1998; Huang et al., 2000) . This is a well-docum-
ented case of what may be a widespread problem in plant engineering: species differences in foreign gene expression. It clearly validates the testing of engineering strategies in more than one species.
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More biochemical and metabolic analyses have been made of COX transformants than of other transgenics mentioned so far, and the results have been very informative. Thus, comparison of rice with COX in the cytosol vs. chloroplasts showed that GlyBet levels were higher when expression was cytosolic (Sakamoto et al., 1998) , which fits with the cytosolic location of choline synthesis (Weretilnyk et al., 1995; Nuccio et al., 2000b) and with other evidence that choline uptake into the chloroplast is a major flux-controlling step (see below). In Arabidopsis, at least 60%
(and perhaps all) of the GlyBet synthesized by chloroplastic COX was found to remain in chloroplasts (Sakamoto et al., 2000) , which is not the case in natural GlyBet accumulators (Rhodes and Hanson, 1993) . Together, these compartmentation studies imply that there exist chloroplastic transporters for choline and GlyBet that are scarce or absent in plants that naturally lack GlyBet.
Providing choline (2-20 mM) to in-vitro cultured Arabidopsis, canola, and tobacco COX transgenics increased GlyBet levels up to 37-fold (Huang et al., 2000) . These experiments, and others with CMO transgenics (see below), demonstrate that flux to GlyBet is severely limited by the internal choline supply. Surprisingly, this constraint was not manifest from a drop in choline or phosphatidylcholine pool sizes (Sakamoto and Murata, 2001) , perhaps due to compartmentation.
This shows how risky it is in plants to rely solely on pool size data to diagnose flux limitations.
A special feature of COX is that it produces H 2 O 2 , which could have deleterious consequences.
This may be the case because H 2 O 2 levels in transgenics are up to double those in controls, and activities of the H 2 O 2 -detoxifying enzymes ascorbate peroxidase and catalase are elevated (Alia et al., 1999) . It is therefore possible that the stress protection seen in COX transgenics is due partly to heightened capacity to deal with oxidative injury. In any case, this is a good example of collateral metabolic damage inflicted by a transgene, and of adaptive response by the host plant.
Engineering with CMO and BADH
CMO from spinach was first expressed in tobacco without BADH, there being some endogenous BADH activity in tobacco (Nuccio et al., 1998) . The transformants showed correct targeting of CMO to chloroplasts but had very low GlyBet levels (20-50 nmol g -1 fresh weight). As for COX transgenics, GlyBet levels rose at least 30-fold when 5 mM choline was added to the medium, pointing to a limited internal choline supply (that was again not heralded by smaller pools of choline or its esters). Another potential constraint on GlyBet synthesis appeared to be low CMO protein level, despite high CMO mRNA levels. Metabolic modeling based on [ 14 C]choline labeling data and in-vivo 31 P NMR analyses was used to further define the constraints on GlyBet synthesis, and hence the processes likely to need additional engineering (McNeil et al., 2000b) . This work revealed that, besides a low capacity for choline synthesis, the import of choline into the chloroplast is a major constraint. The importance of chloroplast choline import was confirmed by a second study using tobacco co-expressing a CMO modified to enhance translation, and sugar beet BADH. These transgenics, whose GlyBet pathway is chloroplastic, were compared with others having a cytosolic pathway constructed with COX and E. coli BADH . Although chloroplastic CMO activity was at least 4-fold higher than cytosolic COX activity, the flux to GlyBet was 10-fold lower in the CMO/BADH plants. Furthermore, modeling of [ 14 C]choline labeling data showed that the observed 14 C flux to GlyBet in CMO/BADH plants could be accounted for only by interposing a low-flux choline transport step upstream of CMO, but that no such transport step was needed to account for the 14 C flux in COX/BADH plants.
The evidence for a limited internal choline supply in tobacco pointed to the need to enhance choline synthesis. In tobacco and other plants, this proceeds mainly via a cytosolic pathway in which phosphoethanolamine is methylated thrice to give phosphocholine, from which choline is releas-ed (Fig. 4) (Weretilnyk et al., 1995; McNeil et al., 2000a) . A single enzyme, phosphoethanolamine N-methyltransferase (PEAMT) mediates all three methylation steps , and this enzyme is only 1-3% as active in tobacco as in the GlyBet accumulator spinach (Nuccio et al., 1998) . Spinach PEAMT was therefore overexpressed in tobacco already harboring CMO and BADH (McNeil et al., 2001) . This increased the level of free choline 50-fold, and that of GlyBet 30-fold, without perturbing phosphatidylcholine level or growth. These results provide a dramatic illustration of the power of an iterative engineering approach guided by flux modeling.
Flux to GlyBet in the CMO/BADH/PEAMT transgenics is nevertheless still limited by choline import into the chloroplast, and apparently also by lack of capacity to produce ethanolamine, the precursor of choline (Fig. 4) 
(McNeil et al., 2001). The ethanolamine limitation was indicated by
an increased choline level when ethanolamine was added to the medium. This limitation prompted the recent cloning of serine decarboxylase (SDC), a soluble, pyridoxal phosphate-dependent enzyme that appears to be the main source of ethanolamine in plants (Rontein et al., 2001 ). The cloning of SDC opens the way to another round of engineering to boost ethanolamine supply.
TREHALOSE
Trehalose accumulation occurs in many bacteria and fungi, and in a few extremely desiccationtolerant higher plants (the so-called resurrection plants, which tolerate complete dehydration and spring back to life upon rehydration) (Goddijn and van Dun, 1999; Iturriaga et al., 2000) . Trehalose is synthesized in two steps from glucose-6-phosphate and uridine diphosphoglucose, via trehalose-6-phosphate (Fig. 5) . The first step is mediated by trehalose phosphate synthase (TPS), and the second by trehalose-6-phosphate phosphatase (TPP) although non-specific phosphatases can also carry out this reaction.
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The engineering of trehalose accumulation in plants has been undertaken not only to improve stress resistance, but also to produce trehalose at low cost for use as a stabilizing agent for pharmaceuticals and other products. The engineering work has been closely entwined with unexpected discoveries about trehalose metabolism in plants, and provides an excellent example of how engineering projects can help to advance basic plant biochemistry.
Since both substrates for TPS are readily available in the cytosol, relatively large amounts of trehalose might be expected to result from installing a cytosolic TPS. However, attempts to do this by constitutively expressing the E. coli TPS gene (otsA) or the yeast gene (TPS1) in tobacco gave plants that accumulated little trehalose (≤0.5 mol g -1 fresh weight) yet showed stunted growth, altered sugar metabolism, and other adverse side-effects (Goddijn et al., 1997; Romero et al., 1997; Pilon-Smits et al., 1998) . Somewhat more trehalose was obtained when a leaf-specific promoter was used in tobacco (Holmstrom et al., 1996) , but none at all was detected in the tubers of potato plants when TPS expression was driven by a tuber-specific promoter (Goddijn et al., 1997) . The low trehalose levels were not explained by failure to hydrolyze trehalose-6-phosphate since this intermediate did not build up, and co-expressing the E. coli gene (otsB) for TPP with TPS made little difference. Nor did the explanation appear to be poor expression of TPS.
Instead, it seems that the main constraint is trehalose degradation. A specific trehalase activityof previously unknown physiological significance -is common in plants (Muller et al., 1995) .
This activity was demonstrated in tobacco leaves and potato tubers. Moreover, when the specific trehalase inhibitor validamycin A was added to culture media, transgenic tobacco accumulated several-fold more trehalose, and transgenic potato tubers accumulated significant amounts (up to 12 mol g -1 fresh weight) for the first time (Goddijn et al., 1997) . Quite unexpectedly, control tobacco plants also accumulated a little trehalose (0.06 mol g -1 fresh weight), providing the first evidence for the presence of an endogenous trehalose synthesis pathway in plants thought to lack it. The existence of this pathway was subsequently confirmed by the identification of TPS and TPP genes from Arabidopsis and other 'trehalose-free' plant species (Goddijn and van Dun, 1999) . The discovery of a cryptic trehalose pathway in plants provides another warning about inferring fluxes from pool size data. In this case, the logic was: "no detectable pool -therefore no flux". And it turned out to be wrong.
In yeast, trehalose is implicated in the control of glycolytic flux and this may apply to plants also, since transgenics with trivial amounts of trehalose show profound disturbances to sugar metabolism and development (Romero et al., 1997; Goddijn and van Dun, 1999) . These disturbances vitiate any stress resistance conferred by trehalose because the trehalose-containing transgenics grow abnormally. Overall, the discovery of trehalose metabolism as a general and perhaps regulatory feature of higher plants is an exciting one for basic plant biochemistry. But it bears stark witness that we need a far deeper understanding of trehalose metabolism in plants before
we can hope to engineer it rationally or use trehalose accumulation to improve stress resistance.
CONCLUSIONS
Metabolic engineering of osmoprotectant pathways works for model plants subjected to more or less artificial laboratory tests of stress resistance. But there is a long path ahead to raise accumulation levels, to overcome intracellular transport constraints, to restrict accumulation to when and where it is needed, to reduce side-effects, and to prove the value of engineered osmoprotectants in major crops under field stress conditions. Some of the tools needed to do this are at hand, others not quite.
Tools that are basically at hand -even if not fully used -include those to estimate in-vivo metabolite fluxes, to target proteins to different subcellular compartments, and to optimize gene expression or limit it to particular organs or stress conditions. Among the tools we still lack are efficient methods to introduce multiple genes (preferably one after another), high-throughput ways to diagnose side effects and their causes, and -most of all -complete metabolic maps and comprehensive public gene collections that include all plant enzymes and transporters. The good news is that all these missing tools are coming, and coming now in the areas of metabolic diagnosis, maps, and gene collections. A combination of metabolic profiling (Fiehn et al., 2000) and gene expression profiling (Zhu and Wang, 2000) can reveal much about how plants react to engineered changes, as well as lead to gene discovery (Trethewey, 2001) . The Arabidopsis genome and plant EST collections coupled with the project to assign functions to all Arabidopsis genes by 2010 (Somerville and Dangl, 2000) will give us more complete metabolic maps, and a fuller set of catalogued genes for plant enzymes and transporters. There is thus good reason to expect significant advances in plant osmoprotectant engineering within the next decade. 
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